The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant gemcitabine (GEM) versus gemcitabine plus capecitabine (GEMCAP) in resected pancreatic adenocarcinoma: A retrospective analysis.
 
Sora Kang
No Relationships to Disclose
 
Changhoon Yoo
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; MSD Oncology; SERVIER
Speakers' Bureau - Bayer; Celgene; Eisai; Ipsen; Merck Sharp & Dohme
Research Funding - AstraZeneca; Bayer; CKD pharm; SERVIER
 
So Heun Lee
No Relationships to Disclose
 
Heung-Moon Chang
No Relationships to Disclose
 
Jae Ho Jeong
No Relationships to Disclose
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose